Ask Warren

Jeil Pharma Holdings

002620 · KOSPI · ₩002620 · 제일파마홀딩스

₩6,720▼ ₩60 (0.88%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩165B₩150B₩154B₩161B₩160B₩182B₩204B₩190B
Cost of sales₩102B₩89B₩91B₩93B₩98B₩123B₩146B₩146B
Gross profit₩63B₩62B₩64B₩68B₩62B₩59B₩58B₩44B
Operating income−₩9.9B₩3.6B₩6.6B₩18B₩6.9B₩7.1B₩3.9B−₩3.3B
Net income−₩11B₩4.5B₩20B₩11B−₩1.7B₩4.6B−₩61B₩21B
Net income to shareholders−₩3.5B₩1.1B₩7.3B₩3.6B₩1.5B₩2.3B−₩37B−₩2.2B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩892B₩878B₩877B₩861B₩846B₩873B₩890B₩882B
Current assets₩395B₩386B₩373B₩367B₩368B₩396B₩410B₩386B
Cash and equivalents₩63B₩58B₩56B₩56B₩57B₩54B₩60B₩37B
Total liabilities₩421B₩403B₩408B₩400B₩400B₩429B₩453B₩450B
Current liabilities₩329B₩317B₩323B₩320B₩324B₩354B₩378B₩381B
Borrowings₩22B₩167B₩166B₩164B₩17B₩12B₩12B₩12B
Total equity₩471B₩475B₩469B₩461B₩446B₩444B₩437B₩432B
Shareholders' equity₩314B₩319B₩319B₩314B₩310B₩309B₩307B₩327B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩4.7B₩447M₩2B₩14B−₩4.7B−₩11B₩2.2B₩1.3B
Capital spending₩6.2B₩1.7B₩2.2B₩2.6B₩2.9B₩565M₩1.7B₩1B
Free cash flow−₩11B−₩1.3B−₩254M₩12B−₩7.6B−₩12B₩459M₩252M
Dividends paid₩2.1B−₩1.1B₩0₩0−₩58,280₩183M₩0₩0

Consolidated where available. Amounts in won.

Also known as: Jeil Pharma Holdings / 제일파마홀딩스 / 002620 / KRX:002620

Source: KRX statistical information